Login / Signup

Volatile Organic Compounds Analysis as a Potential Novel Screening Tool for Breast Cancer: A Systematic Review.

Michelle LeemansPierre BauërVincent CuzuelEtienne AudureauIsabelle Fromantin
Published in: Biomarker insights (2022)
Discrepant VOC results among BC studies have been obtained, highly due to methodological discrepancies. Therefore, methodological issues leading to disparities have been reviewed and recommendations have been made on the standardisation of VOC collection and analysis methods for BC screening, thereby improving future VOC clinical validation studies.
Keyphrases
  • healthcare
  • affordable care act